Report Overview
Report Overview
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term consumption came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
The global Tuberculosis (TB) Diagnostics market size was estimated at USD 3070.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tuberculosis (TB) Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tuberculosis (TB) Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tuberculosis (TB) Diagnostics market.
Global Tuberculosis (TB) Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Market Segmentation (by Type)
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Market Segmentation (by Application)
Diagnostic Laboratories
Hospitals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis (TB) Diagnostics Market
Overview of the regional outlook of the Tuberculosis (TB) Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis (TB) Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis (TB) Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Tuberculosis (TB) Diagnostics
- 1.2 Key Market Segments
- 1.2.1 Tuberculosis (TB) Diagnostics Segment by Type
- 1.2.2 Tuberculosis (TB) Diagnostics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Tuberculosis (TB) Diagnostics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Tuberculosis (TB) Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Tuberculosis (TB) Diagnostics Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Tuberculosis (TB) Diagnostics Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Tuberculosis (TB) Diagnostics Product Life Cycle
- 3.3 Global Tuberculosis (TB) Diagnostics Sales by Manufacturers (2020-2025)
- 3.4 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Tuberculosis (TB) Diagnostics Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Tuberculosis (TB) Diagnostics Market Competitive Situation and Trends
- 3.8.1 Tuberculosis (TB) Diagnostics Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Tuberculosis (TB) Diagnostics Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Tuberculosis (TB) Diagnostics Industry Chain Analysis
- 4.1 Tuberculosis (TB) Diagnostics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Tuberculosis (TB) Diagnostics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Tuberculosis (TB) Diagnostics Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Tuberculosis (TB) Diagnostics Market
- 5.7 ESG Ratings of Leading Companies
- 6 Tuberculosis (TB) Diagnostics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Tuberculosis (TB) Diagnostics Sales Market Share by Type (2020-2025)
- 6.3 Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
- 6.4 Global Tuberculosis (TB) Diagnostics Price by Type (2020-2025)
- 7 Tuberculosis (TB) Diagnostics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Tuberculosis (TB) Diagnostics Market Sales by Application (2020-2025)
- 7.3 Global Tuberculosis (TB) Diagnostics Market Size (M USD) by Application (2020-2025)
- 7.4 Global Tuberculosis (TB) Diagnostics Sales Growth Rate by Application (2020-2025)
- 8 Tuberculosis (TB) Diagnostics Market Sales by Region
- 8.1 Global Tuberculosis (TB) Diagnostics Sales by Region
- 8.1.1 Global Tuberculosis (TB) Diagnostics Sales by Region
- 8.1.2 Global Tuberculosis (TB) Diagnostics Sales Market Share by Region
- 8.2 Global Tuberculosis (TB) Diagnostics Market Size by Region
- 8.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region
- 8.2.2 Global Tuberculosis (TB) Diagnostics Market Size by Region
- 8.3 North America
- 8.3.1 North America Tuberculosis (TB) Diagnostics Sales by Country
- 8.3.2 North America Tuberculosis (TB) Diagnostics Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Tuberculosis (TB) Diagnostics Sales by Country
- 8.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Tuberculosis (TB) Diagnostics Sales by Region
- 8.5.2 Asia Pacific Tuberculosis (TB) Diagnostics Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Tuberculosis (TB) Diagnostics Sales by Country
- 8.6.2 South America Tuberculosis (TB) Diagnostics Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Tuberculosis (TB) Diagnostics Sales by Region
- 8.7.2 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Tuberculosis (TB) Diagnostics Sales by Region
- 9 Tuberculosis (TB) Diagnostics Market Production by Region
- 9.1 Global Production of Tuberculosis (TB) Diagnostics by Region(2020-2025)
- 9.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
- 9.3 Global Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Tuberculosis (TB) Diagnostics Production
- 9.4.1 North America Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
- 9.4.2 North America Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Tuberculosis (TB) Diagnostics Production
- 9.5.1 Europe Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
- 9.5.2 Europe Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Tuberculosis (TB) Diagnostics Production (2020-2025)
- 9.6.1 Japan Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
- 9.6.2 Japan Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Tuberculosis (TB) Diagnostics Production (2020-2025)
- 9.7.1 China Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
- 9.7.2 China Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Danaher
- 10.1.1 Danaher Basic Information
- 10.1.2 Danaher Tuberculosis (TB) Diagnostics Product Overview
- 10.1.3 Danaher Tuberculosis (TB) Diagnostics Product Market Performance
- 10.1.4 Danaher Business Overview
- 10.1.5 Danaher SWOT Analysis
- 10.1.6 Danaher Recent Developments
- 10.2 Roche
- 10.2.1 Roche Basic Information
- 10.2.2 Roche Tuberculosis (TB) Diagnostics Product Overview
- 10.2.3 Roche Tuberculosis (TB) Diagnostics Product Market Performance
- 10.2.4 Roche Business Overview
- 10.2.5 Roche SWOT Analysis
- 10.2.6 Roche Recent Developments
- 10.3 Thermo Fisher Scientific
- 10.3.1 Thermo Fisher Scientific Basic Information
- 10.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Overview
- 10.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Market Performance
- 10.3.4 Thermo Fisher Scientific Business Overview
- 10.3.5 Thermo Fisher Scientific SWOT Analysis
- 10.3.6 Thermo Fisher Scientific Recent Developments
- 10.4 BD
- 10.4.1 BD Basic Information
- 10.4.2 BD Tuberculosis (TB) Diagnostics Product Overview
- 10.4.3 BD Tuberculosis (TB) Diagnostics Product Market Performance
- 10.4.4 BD Business Overview
- 10.4.5 BD Recent Developments
- 10.5 Abbott
- 10.5.1 Abbott Basic Information
- 10.5.2 Abbott Tuberculosis (TB) Diagnostics Product Overview
- 10.5.3 Abbott Tuberculosis (TB) Diagnostics Product Market Performance
- 10.5.4 Abbott Business Overview
- 10.5.5 Abbott Recent Developments
- 10.6 Hologic
- 10.6.1 Hologic Basic Information
- 10.6.2 Hologic Tuberculosis (TB) Diagnostics Product Overview
- 10.6.3 Hologic Tuberculosis (TB) Diagnostics Product Market Performance
- 10.6.4 Hologic Business Overview
- 10.6.5 Hologic Recent Developments
- 10.7 Qiagen
- 10.7.1 Qiagen Basic Information
- 10.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Overview
- 10.7.3 Qiagen Tuberculosis (TB) Diagnostics Product Market Performance
- 10.7.4 Qiagen Business Overview
- 10.7.5 Qiagen Recent Developments
- 10.8 BioMerieux
- 10.8.1 BioMerieux Basic Information
- 10.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Overview
- 10.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product Market Performance
- 10.8.4 BioMerieux Business Overview
- 10.8.5 BioMerieux Recent Developments
- 10.9 Hain Lifescience
- 10.9.1 Hain Lifescience Basic Information
- 10.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Overview
- 10.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product Market Performance
- 10.9.4 Hain Lifescience Business Overview
- 10.9.5 Hain Lifescience Recent Developments
- 10.10 Oxford Immunotec
- 10.10.1 Oxford Immunotec Basic Information
- 10.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Overview
- 10.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Market Performance
- 10.10.4 Oxford Immunotec Business Overview
- 10.10.5 Oxford Immunotec Recent Developments
- 10.1 Danaher
- 11 Tuberculosis (TB) Diagnostics Market Forecast by Region
- 11.1 Global Tuberculosis (TB) Diagnostics Market Size Forecast
- 11.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Tuberculosis (TB) Diagnostics Market Size Forecast by Country
- 11.2.3 Asia Pacific Tuberculosis (TB) Diagnostics Market Size Forecast by Region
- 11.2.4 South America Tuberculosis (TB) Diagnostics Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Tuberculosis (TB) Diagnostics by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Tuberculosis (TB) Diagnostics by Type (2026-2035)
- 12.1.2 Global Tuberculosis (TB) Diagnostics Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Tuberculosis (TB) Diagnostics by Type (2026-2035)
- 12.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2026-2035)
- 12.2.1 Global Tuberculosis (TB) Diagnostics Sales (K Units) Forecast by Application
- 12.2.2 Global Tuberculosis (TB) Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings